Supportive Care in Cancer

, Volume 22, Issue 7, pp 1941–1948 | Cite as

EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer

  • Yong Joo Lee
  • Sang-Yeon Suh
  • Youn Seon Choi
  • Jae Yong Shim
  • Ah-Ram Seo
  • Sung-Eun Choi
  • Hong-Yup Ahn
  • Eunji Yim
Original Article
First Online:
Received:
Accepted:

Abstract

Purpose

Quality of life (QoL) and performance status predict survival in advanced cancer patients; these relationships have not been explored in the hospice palliative care setting. The aim of this study was to examine the survival predictability of patient-reported QoL using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C15-PAL questionnaire in far advanced cancer inpatients at the very end of life.

Methods

This is a retrospective cohort study. Patients reported QoL using the EORTC QLQ-C15-PAL. One hundred sixty-two inpatients in hospice palliative wards of six hospitals in South Korea were followed until death or the end of the study. Additional symptoms and performance status were assessed by the MD Anderson Symptom Inventory—Korean (MDASI-K), Palliative Performance Scale (PPS) and Eastern Cooperative Oncology Group (ECOG) performance status. Correlations between EORTC QLQ-C15-PAL, MDASI-K, PPS, and ECOG were assessed. Survival analyses were performed using Cox proportional hazard models.

Results

Patients’ median survival was less than 1 month. Physician-reported PPS significantly predicted survival (hazard ratio [HR] 0.493; p < 0.001). From the EORTC QLQ-C15-PAL, patient-reported physical functioning predicted survival (HR = 0.65; p < 0.001). Other six domains of EORTC QLQ-C15-PAL were significantly related to survival after adjustment. Those domains were global health status, emotional functioning, fatigue, nausea/vomiting, appetite loss, and constipation.

Conclusions

EORTC QLQ-C15-PAL can be an independent prognostic factor in inpatients with far advanced cancer. Patient-reported physical functioning showed survival predictability as good as physician-reported performance status. It is notable that the QLQ instrument is useful even for patients in their final month of life. Cancer anorexia–cachexia syndrome-related symptoms may be independent prognostic symptoms. Prospective study is warranted.

Keywords

Quality of life Survival EORTC QLQ-C15-PAL Performance status Palliative care 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

We do not have any financial relationships to disclose. We have full control over all primary data and agree to allow Supportive Care in Cancer to review the data.

References

  1. 1.
    Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcome 7:102CrossRefGoogle Scholar
  2. 2.
    Epplein M, Zheng Y, Zheng W et al (2011) Quality of life after breast cancer diagnosis and survival. J Clin Oncol 29:406–412PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ (2011) Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clin Otolaryngol 36:361–368PubMedCrossRefGoogle Scholar
  4. 4.
    Braun DP, Gupta D, Grutsch JF, Staren ED (2011) Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health Qual Life Outcome 9:62CrossRefGoogle Scholar
  5. 5.
    Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109–112PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Park SH, Cho MS, Kim YS et al (2008) Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Qual Life Res 17:207–214PubMedCrossRefGoogle Scholar
  7. 7.
    Efficace F, Bottomley A, Smit EF et al (2006) Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 17:1698–1704PubMedCrossRefGoogle Scholar
  8. 8.
    Lee CK, Stockler MR, Coates AS et al (2010) Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. Br J Cancer 102:1341–1347PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Velikova G, Wright P, Smith AB et al (2001) Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records. J Clin Oncol 19:2064–2073PubMedGoogle Scholar
  10. 10.
    Efficace F, Bottomley A, Coens C et al (2006) Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer 42:42–49PubMedCrossRefGoogle Scholar
  11. 11.
    McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC (2008) The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 98:888–893PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Grande GE, Farquhar MC, Barclay SI, Todd CJ (2009) Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients. Palliat Support Care 7:289–297PubMedCrossRefGoogle Scholar
  13. 13.
    Groenvold M, Petersen MA, Aaronson NK et al (2006) EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliat Med 20:59–61PubMedCrossRefGoogle Scholar
  14. 14.
    Caissie A, Nguyen J, Chen E et al (2012) Quality of life in patients with brain metastases using the EORTC QLQ-BN20 + 2 and QLQ-C15-PAL. Int J Radiat Oncol Biol Phys 83:1238–1245PubMedCrossRefGoogle Scholar
  15. 15.
    Caissie A, Culleton S, Nguyen J et al (2011) EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer 20:841–848PubMedCrossRefGoogle Scholar
  16. 16.
    Lien K, Zeng L, Nguyen J et al (2011) Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer. Expert Rev Pharmacoecon Outcome Res 11:541–547CrossRefGoogle Scholar
  17. 17.
    Suarez-del-Real Y, Allende-Perez S, Alferez-Mancera A et al (2011) Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care. Psychooncology 20:889–896PubMedCrossRefGoogle Scholar
  18. 18.
    Suh SY, Choi YS, Shim JY et al (2010) Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 18:151–157PubMedCrossRefGoogle Scholar
  19. 19.
    Yun YH, Mendoza TR, Kang IO et al (2006) Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manag 31:345–352CrossRefGoogle Scholar
  20. 20.
    Groenvold M, Petersen M, Aaronson N et al (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64PubMedCrossRefGoogle Scholar
  21. 21.
    Mei AH, Jin WL, Hwang MK, Meng YC, Seng LC, Yaw WH (2013) Value of the Palliative Performance Scale in the prognostication of advanced cancer patients in a tertiary care setting. J Palliat Med 16:887–893PubMedCrossRefGoogle Scholar
  22. 22.
    Seow H, Barbera L, Dudgeon D et al (2013) The association of the palliative performance scale and hazard of death in an ambulatory cancer population. J Palliat Med 16:156–162PubMedCrossRefGoogle Scholar
  23. 23.
    Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C (2006) Use of Palliative Performance Scale in end-of-life prognostication. J Palliat Med 9:1066–1075PubMedCrossRefGoogle Scholar
  24. 24.
    Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative Performance Scale (PPS): a new tool. J Palliat Care 12:5–11PubMedGoogle Scholar
  25. 25.
    Cramarossa G, Chow E, Zhang L et al (2013) Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer 21:1709–1716PubMedCrossRefGoogle Scholar
  26. 26.
    Suh SY, Leblanc TW, Shelby RA, Samsa GP, Abernethy AP (2011) Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic. J Oncol Pract 7:374–381PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Quinten C, Coens C, Mauer M et al (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865–871PubMedCrossRefGoogle Scholar
  28. 28.
    Shitara K, Munakata M, Kasai M, Muto O, Sakata Y (2008) Prolongation of survival and improvement in performance status following palliative chemotherapy in gastrointestinal cancer patients with a poor performance status. Oncology 74:135–142PubMedCrossRefGoogle Scholar
  29. 29.
    Sadat F, Wienke A, Dunst J, Kuhnt T (2012) Survival of patients with head and neck cancer. Impact of physical status and comorbidities. Strahlenther Onkol 188:62–70PubMedCrossRefGoogle Scholar
  30. 30.
    Diamond C, Taylor TH, Anton-Culver H (2010) Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res 19:149–155PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Vigano A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME (2000) Clinical survival predictors in patients with advanced cancer. Arch Intern Med 160:861–868PubMedCrossRefGoogle Scholar
  32. 32.
    Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M (2004) Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 101:1090–1098PubMedCrossRefGoogle Scholar
  33. 33.
    Leblanc TW, Back AL (2011) Linking palliative care and oncology practice: performance status as a common thread. J Oncol Pract 7:381–382PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Braun DP, Gupta D, Staren ED (2012) Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer 20:1267–1274PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Lipscomb J, Gotay CC, Snyder CF (2007) Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57:278–300PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Yong Joo Lee
    • 1
  • Sang-Yeon Suh
    • 2
    • 3
  • Youn Seon Choi
    • 4
  • Jae Yong Shim
    • 5
  • Ah-Ram Seo
    • 6
  • Sung-Eun Choi
    • 6
  • Hong-Yup Ahn
    • 6
  • Eunji Yim
    • 3
  1. 1.College of Medicine, The Catholic University of KoreaSeoulSouth Korea
  2. 2.Department of MedicineDongguk University-SeoulSeoulSouth Korea
  3. 3.Department of Family MedicineDongguk University Ilsan HospitalGoyang-si, Gyeonggi-doSouth Korea
  4. 4.Department of Family MedicineKorea University Guro HospitalSeoulSouth Korea
  5. 5.Department of Family MedicineGangnam Severance Hospital, Yonsei University Health SystemSeoulSouth Korea
  6. 6.Department of StatisticsDongguk University-SeoulSeoulSouth Korea

Personalised recommendations